Filtered By:
Condition: Heart Attack
Countries: USA Health

This page shows you your search results in order of relevance. This is page number 11.

Order by Relevance | Date

Total 340 results found since Jan 2013.

Academy of Laser Dentistry Announces Call for Abstracts for ALD 2019 Annual Session
“The Laser-Systemic Connection: Lighting the Way to a Healthier Mouth and Body” will Take Place in Dallas on April 4-6, with Opening Keynoteby Leading Oral-Systemic Health Advocate, Charles Whitney, MDCoral Springs, FL – June 18, 2018 –The Academy of Laser Dentistry (ALD), the only independent and unbiased non-profit association dedicated to improving patient care with the proper use of laser technology, recently issued a call for abstracts for its upcoming annual meeting.Known internationally as “dentistry’s laser meeting”, ALD 2019 is at the Hilton Anatole in Dallas from April 4th– 6th. The meeting ’s f...
Source: Dental Technology Blog - June 22, 2018 Category: Dentistry Source Type: news

Heartfelt sepsis: microvascular injury due to genomic storm.
Abstract Sepsis is one of the ten leading causes of death in developed and developing countries. In the United States, sepsis mortality approaches that of acute myocardial infarction and exceeds deaths from stroke. Neonates and the elderly are the most vulnerable patients, with these groups suffering from the highest sepsis mortality. In both groups, many survivors respectively display serious developmental disabilities and cognitive decline. The National Institute of Health National Heart Lung and Blood Institute Panel redefined sepsis as a "severe endothelial dysfunction syndrome in response to intravascular and...
Source: Polish Heart Journal - July 5, 2018 Category: Cardiology Authors: Hawiger J Tags: Kardiol Pol Source Type: research

Academy of Laser Dentistry Now Accepting Applications for 2019 Seidner Student Scholarship Program
Coral Springs, FL – July 17, 2018 –The Academy of Laser Dentistry (ALD) the only independent and unbiased non-profit association dedicated to improving patient care with the proper use of laser technology, is now accepting applications for theDr. Eugene M. Seidner Student Scholarship Program. Named in the memory of Dr. Seidner, a laser dentistry pioneer who also served as ALD president 1996-1997, three recipients will be honored during the ALD ’s 26th Anniversary Conference& Exhibition,April 4-6th at the Hilton Anatole in Dallas, Texas.According to ALD executive director Gail Siminovsky, CAE, “The ALD is v...
Source: Dental Technology Blog - July 25, 2018 Category: Dentistry Source Type: news

Diabetes risk scores for Hispanics living in the United States: A systematic review
The prevalence of diabetes is increasing worldwide [1 –3]. Diabetes and its vascular complications are the seventh leading cause of disability worldwide and contribute to the deaths of two million adults per year [4]. Type 2 diabetes is the most common type affecting 90–95% of those with diabetes and may be asymptomatic for years [5]. Uncontrolled diabetes leads to microvascular (e.g., neuropathy, nephropathy, retinopathy) and macrovascular (e.g., myocardial infarction, stroke) complications and may increase mortality risk [6,7].
Source: Diabetes Research and Clinical Practice - May 28, 2018 Category: Endocrinology Authors: Lucia D. Juarez, Jeffrey S. Gonzalez, April A. Agne, Andrzej Kulczycki, Gregory Pavela, April P. Carson, John P. Shelley, Andrea L. Cherrington Source Type: research

Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and safety CardioVascular outcomes trial (VERTIS-CV)
ConclusionThe results from the VERTIS-CV trial will define the CV and renal safety and efficacy of ertugliflozin in patients with T2DM and ASCVD.ClinicalTrials.gov identifier: NCT01986881
Source: American Heart Journal - September 6, 2018 Category: Cardiology Source Type: research

Neovasc touts Tiara TMVR success rate in study
A small study of the Neovasc (NSDQ:NVCN) Tiara transcatheter mitral valve replacement (TMVR) in high-risk patients revealed a 100% procedural success rate and immediate elimination of mitral regurgitation. Published in Circulation: Cardiovascular Interventions, the study also showed no death, myocardial infarction, stroke, major bleeding, or access site complications at 30 days. The twelve patients in the study had had a previous aortic valve replacement. Such patients have been excluded from most TMVR trials because of the potential risks of left ventricular outflow tract obstruction or interaction between the TMVR anch...
Source: Mass Device - October 16, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Cardiac Implants Cardiovascular Featured Replacement Heart Valves Research & Development Mayo Clinic neovasc Neovasc Inc. Source Type: news

Clinical Outcomes of Mitral Valve Reoperations in the United States: An Analysis of the Society of Thoracic Surgeons National Database
ConclusionsDespite a high-risk patient profile, surgical outcomes of reoperative MVS were acceptable, particularly in elective cases with prior mitral valve surgery and without endocarditis.
Source: The Annals of Thoracic Surgery - October 24, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Clinical Outcomes of Mitral Valve Reoperations in the United States: An Analysis of the Society of Thoracic Surgeons National Database.
CONCLUSIONS: Despite a high-risk patient profile, surgical outcomes of reoperative MVS were acceptable, particularly in elective cases with prior mitral valve surgery and without endocarditis. PMID: 30365952 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - October 23, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Kilic A, Acker MA, Gleason TG, Sultan I, Vemulapalli S, Thibault D, Ailawadi G, Badhwar V, Thourani V, Kilic A Tags: Ann Thorac Surg Source Type: research

Preventing Broken Hearts
Atherosclerotic cardiovascular disease (ASCVD) remains the most frequent cause of death in women throughout the world. More than 250,000 women die annually in the United States from ASCVD; mortality and morbidity have significantly increased since 1980.1,2 Women are more likely to develop heart failure or die within 5 years of a myocardial infarction (MI) and have a higher risk of stroke than men.2 Although it has been known for some time that women are at significant risk for developing ASCVD, women remain untreated or undertreated.
Source: The Journal for Nurse Practitioners - November 5, 2018 Category: Nursing Authors: J. Casey Elkins, Leigh Minchew Tags: Quality Care for Women ’s Health Source Type: research

Nutrition, risk factors, prevention, and imaging: The 2018 Mario Verani Lecture
AbstractHeart disease has been the leading cause of death in the United States since 1918. Cardiac mortality rates have dramatically decreased in this era of advanced medical and interventional therapies. However, this has been aptly described as “mopping up the floor instead of turning off the faucet.” With this recognition, prevention in cardiology is poised to become a central focus. Within prevention, dietary intervention is recognized as the single largest opportunity for improved cardiovascular outcomes, including improvement or el imination of cardiac risk factors, prevention of myocardial infarction, stroke and...
Source: Journal of Nuclear Cardiology - November 5, 2018 Category: Nuclear Medicine Source Type: research

New Cholesterol Guidelines Focus on Personalized Approach
SATURDAY, Nov. 10, 2018 -- A lifelong approach to lowering cholesterol, starting in some kids as young as 2, is the United States ' best bet to lower everyone ' s risk of heart attack and stroke, according to updated guidelines released Saturday by the...
Source: Drugs.com - Daily MedNews - November 10, 2018 Category: General Medicine Source Type: news

Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis
Conclusion: Given the rising national trend on the use of anticoagulants for various medical necessities, it is imperative that a safe and efficient process be devised on reinstitution of anticoagulation post MGIB to guide Clinicians. Although our study represents a single institutional analysis, it concurs with recent studies that early resumption of anticoagulant following stabilization of MGIB is associated with lower thromboembolic events. Timing for resumption depends largely on the medical reason for anticoagulation; reinstitution by day 7 appear safe for patients on mechanical valve whereas after day 12 maybe approp...
Source: Blood - November 21, 2018 Category: Hematology Authors: Ezekwudo, D. E., Gaikazian, S., Anusim, N., Konde, A. S., Zakalik, D., Huben, M. T., Stender, M., Anderson, J., Jaiyesimi, I. Tags: 332. Antithrombotic Therapy: Poster I Source Type: research

Firefighting and On-Duty Cardiac Deaths
Conclusion Using autopsy data from on-duty fatalities that occurred over a 15-year period, the underlying cardiac pathological conditions associated with sudden cardiac death were investigated among firefighters. Our data suggest a need for updated and improved medical screening for firefighters. Particularly, screening for CHD and cardiac enlargement should be incorporated into a firefighter’s routine screening. Given the important role of EMS in ensuring both civilian and firefighter safety, EMS personnel should be alert to the potential to encounter either sudden cardiac arrest or a myocardial infarction in firefighte...
Source: JEMS Special Topics - November 12, 2018 Category: Emergency Medicine Authors: Denise L. Smith, PhD, FACSM Tags: Training Exclusive Articles Source Type: news

Bariatric surgery reduces incidence of atrial fibrillation: a propensity score –matched analysis
Atrial fibrillation (AF) affects 33.5 million individuals worldwide [1] and it is estimated that the prevalence of AF in the United States will increase 2- to 3-fold over the next 50 years [2]. Patients with AF are more likely to experience a variety of negative health outcomes, including myocardial infarction, heart failure, and stroke [3,4]. In addition to these major health risks, there is a significant economic burden associated with AF, amounting to as much as $26 billion in annual healthcare expenditures in the United States alone [5].
Source: Surgery for Obesity and Related Diseases - November 24, 2018 Category: Surgery Authors: Kevin T. Lynch, J. Hunter Mehaffey, Robert B. Hawkins, Taryn E. Hassinger, Peter T. Hallowell, Jennifer L. Kirby Tags: Original article Source Type: research

Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
Conclusion: The price of alirocumab would have to be reduced considerably to be cost-effective. Because substantial reductions already have occurred, we believe that timely, independent cost-effectiveness analyses can inform clinical and policy discussions of new drugs as they enter the market. Primary Funding Source: University of California, San Francisco, and Institute for Clinical and Economic Review. PMID: 30597485 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - January 1, 2019 Category: Internal Medicine Authors: Kazi DS, Penko J, Coxson PG, Guzman D, Wei PC, Bibbins-Domingo K Tags: Ann Intern Med Source Type: research